Physician profile
David C Plitt
NPI 1144423740
$1,014.53
in general payments reported to CMS, 2019-2025
14 companies · $12.52 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $381 · 2021: $34.69 · 2022: $140 · 2023: $62.56 · 2024: $71.54 · 2025: $12.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $383.72 | 2019-2021 | |
| Amgen INC. | $108.59 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $106.14 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $104.40 | 2019-2023 | |
| Boston Scientific Corporation | $64.33 | 2020-2024 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.22 | 2019-2025 | Lifevest |
| Tactile Systems Technology INC | $31.16 | 2020 | |
| Irhythm Technologies, INC. | $28.84 | 2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $28.58 | 2020 | |
| Medtronic, INC. | $22.22 | 2023 | Micra |
| Esperion Therapeutics, INC. | $21.94 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $21.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.35 | 2021 | |
| Pfizer INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Plitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.